|
[1]
|
The Efficiency of Telmisartan in Hypertension Management as a Monotherapy or Combined; Literature Review
Archives Of Pharmacy Practice,
2021
DOI:10.51847/NqVySmCa4j
|
|
|
|
|
[2]
|
New approach to blood pressure control: Triple combination pill
Trends in Cardiovascular Medicine,
2019
DOI:10.1016/j.tcm.2019.03.002
|
|
|
|
|
[3]
|
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials
Pharmaceutical Research,
2018
DOI:10.1007/s11095-018-2511-5
|
|
|
|
|
[4]
|
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
Hypertension Research,
2017
DOI:10.1038/hr.2016.100
|
|
|
|
|
[5]
|
Triple-combination therapy in the treatment of hypertension: a review of the evidence
Journal of Human Hypertension,
2017
DOI:10.1038/jhh.2017.5
|
|
|
|
|
[6]
|
Efficacy of Initiating Therapy with Amlodipine and Hydrochlorothiazide or Their Combination in Hypertensive Nigerians
Clinical and Experimental Hypertension,
2013
DOI:10.3109/10641963.2013.776570
|
|
|
|